image
bluebird bio, Inc. BLUE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.7
-3.27 %
$ 36.2 M
Market Cap
-0.15
P/E
BALANCE SHEET
460 M ASSETS
-25.67%
Growth Rates
1Year -25.67%
3Years -8.14%
5Years -23.24%
7Years -18.34%
10Years -1.89%
492 M LIABILITIES
15.81%
Growth Rates
1Year 15.81%
3Years 30.85%
5Years 2.14%
7Years 8.54%
10Years 22.34%
-31.5 M EQUITY
-16.21%
Growth Rates
1Year -16.21%
3Years -2.73%
5Years -0.49%
7Years -0.28%
10Years -0.62%
BALANCE SHEET DECOMPOSITION
Balance Sheet bluebird bio, Inc.
image
Current Assets 155 M
Cash & Short-Term Investments 62.3 M
Receivables 3.09 M
Other Current Assets 89.3 M
Non-Current Assets 306 M
Long-Term Investments 0
PP&E 238 M
Other Non-Current Assets 67.8 M
13.54 %19.40 %51.65 %14.74 %Total Assets$460.2m
Current Liabilities 321 M
Accounts Payable 34.3 M
Short-Term Debt 71.5 M
Other Current Liabilities 216 M
Non-Current Liabilities 170 M
Long-Term Debt 0
Other Non-Current Liabilities 170 M
6.98 %14.54 %43.85 %34.63 %Total Liabilities$491.8m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
ASSETS
Cash & Cash Equivalents 62.3 221.8 113.0 161.2 317.7 327.2 402.6 758.5 278.9 164.3 347.8 206.3 67.0 25.6
Short Term Investments 0 0 67.3 138.3 833.5 779.2 982.7 531.6 425.5 353.7 125.7 0 0 3.5
Receivables 3.1 13.0 10.8 11.4 2.4 12.8 0 8.4 0 0 0 0 0 0
Inventory 65.0 22.9 (1.4) (108.5) (149.7) (144.3) (506.1) (11.5) 0 0 0 0 0 0
Other Current Assets 24.3 24.0 8.6 25.6 522.2 32.9 19.8 21.2 28.0 12.0 12.9 10.7 1.5 0.9
Total Current Assets 154.7 281.7 199.5 336.5 1 215.5 1 152.2 1 419.0 1 614.3 724.2 524.0 480.0 212.0 67.8 30.0
PP&E 237.7 267.0 291.4 101.2 346.9 337.1 246.6 199.6 157.0 82.6 15.7 10.9 1.3 0.7
Intangible Assets 9.5 10.4 4.9 0 10.0 14.3 13.2 16.9 20.7 24.5 28.2 0 0 0
Goodwill 5.6 5.6 5.6 5.6 13.1 13.1 13.1 13.1 13.1 13.1 13.1 0 0 0
Long Term Investments 0 0 1.4 97.1 122.9 131.5 506.1 324.2 180.5 347.8 18.4 0 0 0
Other Long Term Assets 52.6 54.3 52.1 53.3 72.8 79.2 44.8 23.9 22.7 10.4 (0.7) 0.8 0.2 0.2
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 460.2 619.2 554.9 593.8 1 781.3 1 727.4 2 242.8 1 900.6 1 118.1 1 002.3 556.7 224.4 69.3 30.9
LIABILITIES
Accounts Payable 34.3 18.5 14.9 25.9 13.8 43.0 17.8 12.9 13.7 6.3 3.0 4.4 2.2 1.8
Short Term Debt 71.5 105.9 88.2 46.3 9.7 40.4 1.4 1.1 0 0 0 0 0 0
Other Current Liabilities 215.6 75.7 52.0 78.5 180.1 131.8 127.2 56.0 54.7 28.1 14.6 5.2 2.1 0.8
Total Current Liabilities 321.5 200.1 128.2 153.0 203.6 223.6 146.4 95.6 74.5 40.4 43.0 34.9 4.6 2.9
Long Term Debt 0 224.4 278.8 66.4 55.7 170.8 153.3 154.7 120.1 61.9 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0 2.7 10.4 8.3 1.9 0.7 0 0
Other Liabilities 170.3 92 K 92 K 93 K 141.1 38.2 41.7 5.0 13.8 13.6 15.3 6.9 120.1 83.1
Total Liabilities 491.8 424.6 358.6 219.5 426.2 442.4 357.8 277.1 248.7 151.8 65.5 72.7 125.1 86.6
EQUITY
Common Stock 1.9 1.9 0.8 0.7 0.7 0.6 0.5 0.5 0.4 0.4 0.3 0.2 3 K 2 K
Retained Earnings (4 501.0) (4 260.3) (3 986.5) (3 719.9) (2 900.5) (2 281.9) (1 498.8) (913.8) (577.7) (314.2) (147.4) (98.7) (73.4) (63.4)
Other Accumulative Comprehensive Income/Loss (2.1) (1.8) (4.1) (2.9) (5.5) (1.9) (3.6) (4.2) (1.1) (2.3) 71 K (1.5) 0 1 K
Total Equity (31.5) 194.5 196.3 374.3 1 355.1 1 285.0 1 885.1 1 623.4 869.4 850.5 491.3 151.7 (55.7) (55.7)
Total Liabilities and Equity 460.2 619.2 554.9 593.8 1 781.3 1 727.4 2 242.8 1 900.6 1 118.1 1 002.3 556.7 224.4 69.3 30.9
SHARES OUTSTANDING
Common Shares Outstanding 9.7 109.8 78.6 68.9 62.2 55.2 52.0 43.5 37.3 34.7 26.5 12.6 22.8 22.8